Before revision:  Since validating drug combinations via direct screening is prohibitively expensive due to combinatorial explosion, recent approaches have applied machine learning to identify synergistic combinations for cancer .
After revision:  Recent approaches have applied machine learning to identify synergistic combinations for cancer .